Interested to learn about the state of cell and gene therapies in Asia? From Tokyo to Taipei, CGTs are revolutionizing healthcare with tailored market access and reimbursement strategies. Read about market-specific challenges and how innovative treatments shape healthcare and improve market access. skp.link/uaf #BetterMarketAccess #CellandGeneTherapy #Healthcare #SimonKucher
Simon-Kucher’s Post
More Relevant Posts
-
Walgreens Specialty Pharmacy's entry into the gene therapy space has everyone talking. Is this a significant move for Walgreens? Will it make gene therapies more accessible and affordable for patients? These are just a few of the questions being asked. Recent articles (links in the comments) from Forbes, MedCity News, Healthcare Finance, and CNBC all suggest that this move will benefit Walgreens and could also benefit patients. What do you think? Share your thoughts in the comments so we can learn together. #Walgreens #SpecialtyPharmacy #GeneTherapy #Healthcare #PatientCare #MedicalAdvancements
-
-
Healthcare | Marketing Communications | Operations Leadership | Culture Champion
Cellular & gene therapy is reshaping healthcare, shifting from managing to offering potential cures for diseases. With 24 FDA-approved therapies and nearly 300 in development, spending could hit $25B by 2026. But high costs & complex delivery pose challenges. Here are the top four challenges that are top of mind for healthcare systems, and strategies to manage them.
-
Helping life sciences companies navigate the complex global pricing and market access landscape | Executive Account Director at EVERSANA
Explore how 2023's surge in gene therapy approvals is revolutionizing disease treatment, yet faces major pricing and reimbursement challenges. Join the discussion on finding a sustainable balance between innovation and affordability in healthcare!
🌐 NAVLIN DAILY's Trend Spotlight: Day 5 of 2023's Biggest Developments 🧬 🔬 Focus: The Ongoing Battle with Gene Therapy Pricing & Reimbursement Challenges 🚀 Key Insights: 1️⃣ 2023 continues to see a steady stream of gene therapy approvals, each bringing groundbreaking potential in treating various diseases. 2️⃣ Despite their promise, these therapies face significant hurdles in pricing and reimbursement, challenging healthcare systems and payers alike. 3️⃣ Striking a balance between innovation and affordability remains a key issue, with stakeholders seeking sustainable models to support these advanced treatments. 🔗 Dive deeper into this complex topic with the full article: https://lnkd.in/dpg786Kn 📊 Stay tuned as we unravel the pivotal trends shaping our world in 2023! #eversana #navlin #navlindaily #globalpricing #marketaccess #globaldata #innovation #pharmanews #genetherapy #healthcaretrends #InnovationVsAffordability
-
-
Day 5 of NAVLIN by EVERSANA's top trends of 2023: the pricing and reimbursement challenges that accompany the approval of high-priced gene therapies. To learn more about the solutions payers and other stakeholders are considering to ensure access to these life-changing treatments, check out the full Insight: https://lnkd.in/dpg786Kn
🌐 NAVLIN DAILY's Trend Spotlight: Day 5 of 2023's Biggest Developments 🧬 🔬 Focus: The Ongoing Battle with Gene Therapy Pricing & Reimbursement Challenges 🚀 Key Insights: 1️⃣ 2023 continues to see a steady stream of gene therapy approvals, each bringing groundbreaking potential in treating various diseases. 2️⃣ Despite their promise, these therapies face significant hurdles in pricing and reimbursement, challenging healthcare systems and payers alike. 3️⃣ Striking a balance between innovation and affordability remains a key issue, with stakeholders seeking sustainable models to support these advanced treatments. 🔗 Dive deeper into this complex topic with the full article: https://lnkd.in/dpg786Kn 📊 Stay tuned as we unravel the pivotal trends shaping our world in 2023! #eversana #navlin #navlindaily #globalpricing #marketaccess #globaldata #innovation #pharmanews #genetherapy #healthcaretrends #InnovationVsAffordability
-
-
Cell and gene therapies (CGTs) have the potential to revolutionize healthcare by treating and curing previously incurable diseases. With a projected compound annual growth rate of 46%, the global market for CGTs is set to reach $37B over the next five years. However, challenges in reimbursement and operating margins hinder commercial viability. To bridge the gap, leaders must focus on pricing strategies and reducing manufacturing costs. How to make cell and gene therapies financially sustainable > https://owy.mn/45NOFcS #OWHealth #CellandGeneTherapy #healthcare
-
-
Pfizer Ends Muscle Illness Trial for Gene Therapy Following Fatal Event . Read Full News: https://lnkd.in/dfT-XyJU . #MuscularDystrophy #GeneTherapy #ClinicalTrial #MedicalResearch #DuchenneMuscularDystrophy #Healthcare #dxbnewsnetwork #breakingnews #headlines #trendingnews #dxbnews #dxbdnn
-
-
“By removing the delivery barriers that have limited gene therapy, SonoThera opens up new opportunities to treat multiple diseases.” Thomas Willis, Partner, Illumina Ventures. Meet SonoThera our December Portfolio Company Spotlight. Learn how the company is developing novel technology that could unleash new genetic medicines with expanded patient access. https://lnkd.in/gq-7xZdF #partnernews #biotech #genetherapy #therapeutics #SonoThera "
-
-
Health Is Wealth From GLP-1 to individualised gene therapies, healthcare is back in the story. But in a fast-moving and differentiated market, selection is everything. Register: https://ow.ly/2wiw50R6qRe Nudgem Richyal #JOHCM #GlobalEquities #Healthcare
Health Is Wealth
brighttalk.com
-
Health Is Wealth From GLP-1 to individualised gene therapies, healthcare is back in the story. But in a fast-moving and differentiated market, selection is everything. Register: https://ow.ly/ewwq50R43v3 Nudgem Richyal #JOHCM #GlobalEquities #Healthcare
Health Is Wealth
brighttalk.com
-
What do you believe are the keys to facilitating the journey from scientific breakthroughs to real-world applications?
Fractional CTO - Helping biotech leaders turn biologics and technologies into commercial products | CMC Development and Manufacturing | Project Management | Business Strategy
Are you finding the path to commercializing cell and gene therapies complex and uncertain? Join us as we explore this intricate landscape with our guest, Wajiha Ali. Highlights: - Uncover the hurdles of patient referrals and manufacturing regulations, amplifying the complexity of these therapies. - Explore essential commercialization strategies and infrastructure needs while balancing innovation with necessity. -Learn about navigating regulatory scrutiny and stakeholder management for safer, more accessible therapies. What do you believe are the keys to facilitating the journey from scientific breakthroughs to real-world applications? #cellculture #processdevelopment #bioprocessing #celltherapymanufacturing #cellandgenetherapy #leadbiotech
-
